FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

René Verheijen

Research Profile

Disorders

Living Beings

Papillomaviridae

Genes & Molecular Sequences

Chemicals & Drugs

Physiology

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Jacob P Hoogendam; Paulus van Diest; Wouter B Veldhuis; René H M Verheijen; Monique G G Hobbelink; Ronald P Zweemer
Preoperative sentinel node mapping with (99m)Tc-nanocolloid SPECT-CT significantly reduces the intraoperative sentinel node retrieval time in robot assisted laparoscopic cervical cancer surgery.
Afra Zaal; Ronald P Zweemer; P M J J Berns; Isabelle Cadron; Oscar Krijgsman; Gerrit A Meijer; Wouter J Peyrot; Jurgen M J Piek; Petra J Timmers; J Baptist Trimbos; Maria E L van der Burg; Paulus van Diest; Wessel N van Wieringen; Jan H W Veerbeek; Ignace Vergote; René H M Verheijen; Bauke Ylstra
Genomic aberrations relate early and advanced stage ovarian cancer.
Jonathan Gene Bijron; Laura M S Seeber; Daisy M D S Sie-Go; Petra van Der Groep; Eleonora B van Dorst; René H M Verheijen; Paulus van Diest
Promoter hypermethylation patterns in fallopian tube epithelium of BRCA1 and BRCA2 germ line mutation carriers.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of René Verheijen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jacob P Hoogendam; Paulus van Diest; Wouter B Veldhuis; René H M Verheijen; Monique G G Hobbelink; Ronald P Zweemer
Preoperative sentinel node mapping with (99m)Tc-nanocolloid SPECT-CT significantly reduces the intraoperative sentinel node retrieval time in robot assisted laparoscopic cervical cancer surgery.
Gynecologic oncology 2013;129(2):389-94.
2012: Afra Zaal; Ronald P Zweemer; P M J J Berns; Isabelle Cadron; Oscar Krijgsman; Gerrit A Meijer; Wouter J Peyrot; Jurgen M J Piek; Petra J Timmers; J Baptist Trimbos; Maria E L van der Burg; Paulus van Diest; Wessel N van Wieringen; Jan H W Veerbeek; Ignace Vergote; René H M Verheijen; Bauke Ylstra
Genomic aberrations relate early and advanced stage ovarian cancer.
Cellular oncology (Dordrecht) 2012;35(3):181-8.
2012: Jonathan Gene Bijron; Laura M S Seeber; Daisy M D S Sie-Go; Petra van Der Groep; Eleonora B van Dorst; René H M Verheijen; Paulus van Diest
Promoter hypermethylation patterns in fallopian tube epithelium of BRCA1 and BRCA2 germ line mutation carriers.
Endocrine-related cancer 2012;19(1):69-81.
2012: René H M Verheijen; Paolo Zola; David Cibula; Nicolas Reed
Cancer antigen 125: lost to follow-up?: a European society of gynaecological oncology consensus statement.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2012;22(1):170-4.
2011: Renée M Overmeer; Peter J F Snijders; Johannes Berkhof; Nathalie Fransen Daalmeijer; Daniëlle A M Heideman; Albertus T Hesselink; Jacqueline A Louwers; Chris J L M Meijer; Folkert J van Kemenade; René H M Verheijen; Saskia M Wilting; Afra Zaal; W Marchien van Baal; Renske D M Steenbergen
Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive women.
International journal of cancer. Journal international du cancer 2011;129(9):2218-25.
2011: Laura M S Seeber; Nicole Horrée; Marc Vooijs; A Peter M Heintz; ELSKEN VAN DER WALL; René H M Verheijen; Paulus van Diest
The role of hypoxia inducible factor-1alpha in gynecological cancer.
Critical reviews in oncology/hematology 2011;78(3):173-84.
2011: Ja Louwers; A Zaal; M Kocken; Wa Ter Harmsel; Gcm Graziosi; Jwm Spruijt; Johannes Berkhof; C Balas; E Papagiannakis; Pjf Snijders; Cjlm Meijer; Fj van Kemenade; René H M Verheijen
Dynamic spectral imaging colposcopy: higher sensitivity for detection of premalignant cervical lesions.
BJOG : an international journal of obstetrics and gynaecology 2011;118(3):309-18.
2011: René H M Verheijen
Comparing bivalent and quadrivalent HPV vaccines.
BMJ (Clinical research ed.) 2011;343():d5720.
2011: Leen Verleye; Petronella B Ottevanger; Gunnar Kristensen; Tom Ehlen; Nick Johnson; Maria E L van der Burg; Nick S Reed; René H M Verheijen; Katja N Gaarenstroom; Berit Mosgaard; Jose M Seoane; Jacobus van der Velden; Robert Lotocki; Winette van der Graaf; Björn Penninckx; Corneel Coens; Gavin Stuart; Ignace Vergote
Quality of pathology reports for advanced ovarian cancer: are we missing essential information? An audit of 479 pathology reports from the EORTC-GCG 55971/NCIC-CTG OV13 neoadjuvant trial.
European journal of cancer (Oxford, England : 1990) 2011;47(1):57-64.
2010: D C Rijkaart; V M H Coupe; Folkert J van Kemenade; Daniëlle A M Heideman; Albertus T Hesselink; willem verweij; Lawrence Rozendaal; René H M Verheijen; Peter J F Snijders; Johannes Berkhof; C J L M Meijer
Comparison of Hybrid capture 2 testing at different thresholds with cytology as primary cervical screening test.
British journal of cancer 2010;103(7):939-46.
2010: Ignace Vergote; Claes G Tropé; Frédéric Amant; Gunnar Kristensen; Tom Ehlen; Nick Johnson; René H M Verheijen; Maria E L van der Burg; Angel J Lacave; Pierluigi Benedetti Panici; Gemma G Kenter; Antonio Casado; Cesar Mendiola; Corneel Coens; Leen Verleye; Gavin C E Stuart; Sergio Pecorelli; Nick S Reed
Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.
The New England journal of medicine 2010;363(10):943-53.
2010: Laura M S Seeber; Ronald P Zweemer; LUIGI MARCHIONNI; Leon F A G Massuger; Vincent T H B M Smit; W Marchien van Baal; René H M Verheijen; Paulus van Diest
Methylation profiles of endometrioid and serous endometrial cancers.
Endocrine-related cancer 2010;17(3):663-73.
2010: Jacob P Hoogendam; Wenche M Klerkx; Gerard A P de Kort; Shandra Bipat; Ronald P Zweemer; Daisy M D S Sie-Go; René H M Verheijen; Willem P T M Mali; Wouter B Veldhuis
The influence of the b-value combination on apparent diffusion coefficient based differentiation between malignant and benign tissue in cervical cancer.
Journal of magnetic resonance imaging : JMRI 2010;32(2):376-82.
2010: Dorien C Rijkaart; Johannes Berkhof; Folkert J van Kemenade; Lawrence Rozendaal; René H M Verheijen; Saskia Bulk; Miriam E Herreilers; willem verweij; Peter J F Snijders; Chris J L M Meijer
Comparison of HPV and cytology triage algorithms for women with borderline or mild dyskaryosis in population-based cervical screening (VUSA-screen study).
International journal of cancer. Journal international du cancer 2010;126(9):2175-81.
2010: Laura M S Seeber; Ronald P Zweemer; René H M Verheijen; Paulus van Diest
Hypoxia-inducible factor-1 as a therapeutic target in endometrial cancer management.
Obstetrics and gynecology international 2010;2010():580971.
2010: Jacqueline A Louwers; Mariëlle Kocken; Joyce C van der Bijl; Johannes Berkhof; Peter J F Snijders; Chris J L M Meijer; René H M Verheijen
Colposcopic characteristics of high-risk human papillomavirus-related cervical lesions.
Journal of lower genital tract disease 2010;14(1):49-55.
2009: Marjolijn B Verbruggen; Nathalie L G Sieben; Guido M J M Roemen; Davy A P Rockx; Paulus van Diest; René H M Verheijen; Josephine C Dorsman
v-Raf murine sarcoma viral oncogene mutation status in serous borderline ovarian tumors and the effect on clinical behavior.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2009;19(9):1560-3.
2009: Jurgen M J Piek; René H M Verheijen; Paulus van Diest
Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective.
Histopathology 2009;54(4):494-5.
2009: Catharina M Korse; Johannes M G Bonfrer; Marc van Beurden; René H M Verheijen; Matti A Rookus
Estradiol and testosterone levels are lower after oophorectomy than after natural menopause.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2009;30(1):37-42.
2009: Marjolijn B Verbruggen; Paulus van Diest; Jan P Baak; Mark A M Broeckaert; Peter Kenemans; René H M Verheijen
The prognostic and clinical value of morphometry and DNA cytometry in borderline ovarian tumors: a prospective study.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2009;28(1):35-40.
2009: Marieke O Verhoeven; Marius J van der Mooren; Tom Teerlink; René H M Verheijen; Peter G Scheffer; Peter Kenemans
The influence of physiological and surgical menopause on coronary heart disease risk markers.
Menopause (New York, N.Y.) 2009;16(1):37-49.
2008: María Moreno; Berber M Mol; Silvia von Mensdorff-Pouilly; René H M Verheijen; B Mary E von Blomberg; Alfons J M van den Eertwegh; Rik J Scheper; Hetty J Bontkes
Toll-like receptor agonists and invariant natural killer T-cells enhance antibody-dependent cell-mediated cytotoxicity (ADCC).
Cancer letters 2008;272(1):70-6.
2008: A L M Oei; María Moreno; René H M Verheijen; Fred C G J Sweep; Chris M G Thomas; L F A G Massuger; Silvia von Mensdorff-Pouilly
Induction of IgG antibodies to MUC1 and survival in patients with epithelial ovarian cancer.
International journal of cancer. Journal international du cancer 2008;123(8):1848-53.
2008: María Moreno; Johan Molling; Silvia von Mensdorff-Pouilly; René H M Verheijen; B Mary E von Blomberg; Alfons J M van den Eertwegh; Rik J Scheper; Hetty J Bontkes
In vitro expanded human invariant natural killer T-cells promote functional activity of natural killer cells.
Clinical immunology (Orlando, Fla.) 2008;129(1):145-54.
2008: Peter Kenemans; Rob A Verstraeten; René H M Verheijen
Oncogenic pathways in hereditary and sporadic breast cancer.
Maturitas 2008;61(1-2):141-50.
2008: María Moreno; Johan Molling; Silvia von Mensdorff-Pouilly; René H M Verheijen; Erik Hooijberg; Duco Kramer; Anneke W Reurs; Alfons J M van den Eertwegh; B Mary E von Blomberg; Rik J Scheper; Hetty J Bontkes
IFN-gamma-producing human invariant NKT cells promote tumor-associated antigen-specific cytotoxic T cell responses.
Journal of immunology (Baltimore, Md. : 1950) 2008;181(4):2446-54.
2008: Ate G J van der Zee; M H M Oonk; Joanne A de Hullu; Anca C Ansink; Ignace Vergote; René H M Verheijen; Angelo Maggioni; Katja N Gaarenstroom; Peter J Baldwin; Eleonora B L van Dorst; Jacobus van der Velden; Ralph H Hermans; Hans van der Putten; Pierre Drouin; Achim Schneider; Wim J Sluiter
Sentinel node dissection is safe in the treatment of early-stage vulvar cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(6):884-9.
2008: Jurgen M J Piek; Paulus van Diest; René H M Verheijen
Ovarian carcinogenesis: an alternative hypothesis.
Advances in experimental medicine and biology 2008;622():79-87.
2008: Elvira M Davelaar; Jonas van de Lande; Silvia von Mensdorff-Pouilly; Marinus A Blankenstein; René H M Verheijen; Peter Kenemans
A combination of serum tumor markers identifies high-risk patients with early-stage squamous cervical cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2008;29(1):9-17.
2007: N W J Bulkmans; Johannes Berkhof; Lawrence Rozendaal; Folkert J van Kemenade; A Joan P Boeke; Saskia Bulk; Feja J Voorhorst; René H M Verheijen; K van Groningen; Mathilde E Boon; W Ruitinga; Marjolein van Ballegooijen; Peter J F Snijders; C J L M Meijer
Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial.
Lancet 2007;370(9601):1764-72.
2007: María Moreno; Hetty J Bontkes; Rik J Scheper; Peter Kenemans; René H M Verheijen; Silvia von Mensdorff-Pouilly
High level of MUC1 in serum of ovarian and breast cancer patients inhibits huHMFG-1 dependent cell-mediated cytotoxicity (ADCC).
Cancer letters 2007;257(1):47-55.
2007: Marlies E Nowee; Josephine C Dorsman; Jurgen M J Piek; V M Kosma; K Hämäläinen; René H M Verheijen; Paulus van Diest
HER-2/neu and p27Kip1 in progression of Fallopian tube carcinoma: an immunohistochemical and array comparative genomic hybridization study.
Histopathology 2007;51(5):666-73.
2007: Jurgen M J Piek; Peter Kenemans; Ronald P Zweemer; Paulus van Diest; René H M Verheijen
Ovarian carcinogenesis, an alternative theory.
Gynecologic oncology 2007;107(2):355.
2007: Marlies E Nowee; Antoine M Snijders; Davy A P Rockx; R M de Wit; V M Kosma; K Hämäläinen; Jan P Schouten; René H M Verheijen; Paulus van Diest; Donna G Albertson; Josephine C Dorsman
DNA profiling of primary serous ovarian and fallopian tube carcinomas with array comparative genomic hybridization and multiplex ligation-dependent probe amplification.
The Journal of pathology 2007;213(1):46-55.
2007: Jonas van de Lande; Bas Torrenga; Pieter G H M Raijmakers; Otto S Hoekstra; Marchien W van Baal; Hans A M Brölmann; René H M Verheijen
Sentinel lymph node detection in early stage uterine cervix carcinoma: a systematic review.
Gynecologic oncology 2007;106(3):604-13.
2007: M B Verbruggen; Ronald P Zweemer; Jurgen M J Piek; G A van Unnik; Paulus van Diest; Johan J P Gille; Fred H Menko; Josephine C Dorsman; René H M Verheijen
A case of loss of heterozygosity in the BRCA2 gene of a borderline ovarian tumor: case report and review of literature.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2007;17(5):1143-7.
2007: Saskia Bulk; N W J Bulkmans; Johannes Berkhof; Lawrence Rozendaal; A Joan P Boeke; René H M Verheijen; Peter J F Snijders; Chris J L M Meijer
Risk of high-grade cervical intra-epithelial neoplasia based on cytology and high-risk HPV testing at baseline and at 6-months.
International journal of cancer. Journal international du cancer 2007;121(2):361-7.
2007: Brenda B J Hermsen; René H M Verheijen; Fred H Menko; Johan J P Gille; K van Uffelen; Marinus A Blankenstein; Sybren Meijer; Paulus van Diest; Peter Kenemans; Silvia von Mensdorff-Pouilly
Humoral immune responses to MUC1 in women with a BRCA1 or BRCA2 mutation.
European journal of cancer (Oxford, England : 1990) 2007;43(10):1556-63.
2007: A L M Oei; René H M Verheijen; Michael Seiden; Benedict B Benigno; Alberto Lopes; John Soper; Agamemnon A Epenetos; L F A G Massuger
Decreased intraperitoneal disease recurrence in epithelial ovarian cancer patients receiving intraperitoneal consolidation treatment with yttrium-90-labeled murine HMFG1 without improvement in overall survival.
International journal of cancer. Journal international du cancer 2007;120(12):2710-4.
2007: Brenda B J Hermsen; Roelien I Olivier; René H M Verheijen; Marc van Beurden; Joanne A de Hullu; L F A G Massuger; Curt W Burger; Cecile T M Brekelmans; Marian J E Mourits; Geertruida H de Bock; Katja N Gaarenstroom; Hester Van Boven; T M Mooij; Matti A Rookus
No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study.
British journal of cancer 2007;96(9):1335-42.
2007: Manon van Seters; Fiebo J W Ten Kate; Marc van Beurden; René H M Verheijen; C J L M Meijer; M P M Burger; Theo J M Helmerhorst
In the absence of (early) invasive carcinoma, vulvar intraepithelial neoplasia associated with lichen sclerosus is mainly of undifferentiated type: new insights in histology and aetiology.
Journal of clinical pathology 2007;60(5):504-9.
2007: Brenda B J Hermsen; Silvia von Mensdorff-Pouilly; Johannes Berkhof; Paulus van Diest; Johan J P Gille; Fred H Menko; Marinus A Blankenstein; Peter Kenemans; René H M Verheijen
Serum CA-125 in relation to adnexal dysplasia and cancer in women at hereditary high risk of ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(11):1383-9.
2007: Veerle M H Coupé; Johannes Berkhof; René H M Verheijen; C J L M Meijer
Cost-effectiveness of human papillomavirus testing after treatment for cervical intraepithelial neoplasia.
BJOG : an international journal of obstetrics and gynaecology 2007;114(4):416-24.
2007: Aagje G Bais; Folkert J van Kemenade; Johannes Berkhof; René H M Verheijen; Peter J F Snijders; Feja J Voorhorst; Milena Babović; Marjolein van Ballegooijen; Theo J M Helmerhorst; Chris J L M Meijer
Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs.
International journal of cancer. Journal international du cancer 2007;120(7):1505-10.
2007: Murat Gök; Veerle M H Coupé; Johannes Berkhof; René H M Verheijen; Theo J M Helmerhorst; Cornelis J A Hogewoning; Peter J F Snijders; Chris J L M Meijer
HPV16 and increased risk of recurrence after treatment for CIN.
Gynecologic oncology 2007;104(2):273-5.
2006: J A Green; Petronella Berns; Corneel Coens; I van Luijk; J Thompson-Hehir; Paulus van Diest; René H M Verheijen; M van de Vijver; P van Dam; Gemma G Kenter; Wiebren Tjalma; Patricia C Ewing; I Teodorovic; Ignace Vergote; M E L van der Burg
Alterations in the p53 pathway and prognosis in advanced ovarian cancer: a multi-factorial analysis of the EORTC Gynaecological Cancer group (study 55865).
European journal of cancer (Oxford, England : 1990) 2006;42(15):2539-48.
2006: Jurgen M J Piek; Josephine C Dorsman; L F A G Massuger; Anca C Ansink; Jitske Weegenaar; Avi Shvarts; Peter Kenemans; René H M Verheijen
BRCA1 and p53 protein expression in cultured ovarian surface epithelial cells derived from women with and without a BRCA1 germline mutation.
Archives of gynecology and obstetrics 2006;274(6):327-31.
2006: Brenda B J Hermsen; Paulus van Diest; Johannes Berkhof; Fred H Menko; Johan J P Gille; Jurgen M J Piek; Sybren Meijer; Henri A H Winters; Peter Kenemans; Silvia von Mensdorff-Pouilly; René H M Verheijen
Low prevalence of (pre) malignant lesions in the breast and high prevalence in the ovary and Fallopian tube in women at hereditary high risk of breast and ovarian cancer.
International journal of cancer. Journal international du cancer 2006;119(6):1412-8.
2006: M E Craanen; B van Triest; René H M Verheijen; C J J Mulder
Thalidomide in refractory haemorrhagic radiation induced proctitis.
Gut 2006;55(9):1371-2.
2006: Joanna B Madalinska; Marc van Beurden; Eveline M A Bleiker; Heiddis B Valdimarsdottir; Judith Hollenstein; L F A G Massuger; Katja N Gaarenstroom; Marian J E Mourits; René H M Verheijen; Eleonora B L van Dorst; Hans van der Putten; Ko van der Velden; Henk Boonstra; Neil K Aaronson
The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(22):3576-82.
2006: Marjolijn B Verbruggen; René H M Verheijen; Frank R W van de Goot; Marc van Beurden; Josephine C Dorsman; Paulus van Diest
Serous borderline tumor of the ovary presenting with cervical lymph node involvement: a report of 3 cases.
The American journal of surgical pathology 2006;30(6):739-43.
2006: Petra van Der Groep; A Bouter; R van der Zanden; I Siccama; Fred H Menko; J J P Gille; C van Kalken; ELSKEN VAN DER WALL; René H M Verheijen; Paulus van Diest
Distinction between hereditary and sporadic breast cancer on the basis of clinicopathological data.
Journal of clinical pathology 2006;59(6):611-7.
2006: Antoinette A T P Brink; Peter J F Snijders; Chris J L M Meijer; Johannes Berkhof; René H M Verheijen
HPV testing in cervical screening.
Best practice & research. Clinical obstetrics & gynaecology 2006;20(2):253-66.
2006: Johannes Berkhof; Martine C de Bruijne; Gilda D Zielinski; N W J Bulkmans; Lawrence Rozendaal; Peter J F Snijders; René H M Verheijen; Chris J L M Meijer
Evaluation of cervical screening strategies with adjunct high-risk human papillomavirus testing for women with borderline or mild dyskaryosis.
International journal of cancer. Journal international du cancer 2006;118(7):1759-68.
2006: René H M Verheijen; L F A G Massuger; Benedict B Benigno; Agamemnon A Epenetos; Alberto Lopes; John Soper; Janica Markowska; Rostislav Vyzula; Tom Jobling; Gordon Stamp; Gregory Spiegel; Dennis Thurston; Theo Falke; Joanna Lambert; Michael Seiden
Phase III trial of intraperitoneal therapy with yttrium-90-labeled HMFG1 murine monoclonal antibody in patients with epithelial ovarian cancer after a surgically defined complete remission.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(4):571-8.
2005: Joanna B Madalinska; Judith Hollenstein; Eveline M A Bleiker; Marc van Beurden; Heiddis B Valdimarsdottir; L F A G Massuger; Katja N Gaarenstroom; Marian J E Mourits; René H M Verheijen; Eleonora B L van Dorst; Hans van der Putten; Ko van der Velden; Henk Boonstra; Neil K Aaronson
Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):6890-8.
2005: Nienke E van Trommel; L F A G Massuger; René H M Verheijen; Fred C G J Sweep; Chris M G Thomas
The curative effect of a second curettage in persistent trophoblastic disease: a retrospective cohort survey.
Gynecologic oncology 2005;99(1):6-13.
2005: Aagje G Bais; Matejka Rebolj; Peter J F Snijders; Frits A de Schipper; Dries A J van der Meulen; René H M Verheijen; Feja J Voorhorst; Marjolein van Ballegooijen; Chris J L M Meijer; Theo J M Helmerhorst
Triage using HPV-testing in persistent borderline and mildly dyskaryotic smears: proposal for new guidelines.
International journal of cancer. Journal international du cancer 2005;116(1):122-9.
2005: Silvia von Mensdorff-Pouilly; Leo Kinarsky; Katja Engelmann; Stephan E Baldus; René H M Verheijen; Michael A Hollingsworth; Vladimir Pisarev; Simon Sherman; Franz-Georg Hanisch
Sequence-variant repeats of MUC1 show higher conformational flexibility, are less densely O-glycosylated and induce differential B lymphocyte responses.
Glycobiology 2005;15(8):735-46.
2005: Brenda B J Hermsen; Silvia von Mensdorff-Pouilly; Hans F J Fabry; Henri A H Winters; Peter Kenemans; René H M Verheijen; Paulus van Diest
Lobulitis is a frequent finding in prophylactically removed breast tissue from women at hereditary high risk of breast cancer.
The Journal of pathology 2005;206(2):220-3.
2005: Saskia Bulk; Otto J Visser; Lawrence Rozendaal; René H M Verheijen; Chris J L M Meijer
Cervical cancer in the Netherlands 1989-1998: Decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women.
International journal of cancer. Journal international du cancer 2005;113(6):1005-9.
2005: J B Vermorken; M K B Parmar; Mark F Brady; Elizabeth A Eisenhauer; T Hogberg; Robert F Ozols; J Rochon; Gordon J S Rustin; S Sagae; René H M Verheijen
Clinical trials in ovarian carcinoma: study methodology.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16 Suppl 8():viii20-viii29.
2004: Rik Pijpers; Marrije R Buist; Arthur van Lingen; Jan Dijkstra; Paulus van Diest; Gerrit J J Teule; Peter Kenemans; René H M Verheijen
The sentinel node in cervical cancer: scintigraphy and laparoscopic gamma probe-guided biopsy.
European journal of nuclear medicine and molecular imaging 2004;31(11):1479-86.
2004: Peter Kenemans; Rob A Verstraeten; René H M Verheijen
Oncogenic pathways in hereditary and sporadic breast cancer.
Maturitas 2004;49(1):34-43.
2004: Jurgen M J Piek; Peter Kenemans; René H M Verheijen
Intraperitoneal serous adenocarcinoma: a critical appraisal of three hypotheses on its cause.
American journal of obstetrics and gynecology 2004;191(3):718-32.
2004: Gilda D Zielinski; Aagje G Bais; Theo J M Helmerhorst; René H M Verheijen; Frits A de Schipper; Peter J F Snijders; Feja J Voorhorst; Folkert J van Kemenade; Lawrence Rozendaal; C J L M Meijer
HPV testing and monitoring of women after treatment of CIN 3: review of the literature and meta-analysis.
Obstetrical & gynecological survey 2004;59(7):543-53.
2004: N W J Bulkmans; Lawrence Rozendaal; Peter J F Snijders; Feja J Voorhorst; A Joan P Boeke; Gladys R J Zandwijken; Folkert J van Kemenade; René H M Verheijen; Krijn v Groningen; Mathilde E Boon; Hans J F Keuning; Marjolein van Ballegooijen; Adriaan J C van den Brule; Chris J L M Meijer
POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women.
International journal of cancer. Journal international du cancer 2004;110(1):94-101.
2004: Petra van Der Groep; Alwin Bouter; Richard van der Zanden; Fred H Menko; Horst Buerger; René H M Verheijen; ELSKEN VAN DER WALL; Paulus van Diest
Re: Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer.
Journal of the National Cancer Institute 2004;96(9):712-3; author reply 714.
2004: Jurgen M J Piek; Josephine C Dorsman; Avi Shvarts; Anca C Ansink; L F A G Massuger; Piet Scholten; Paulus van Diest; Jan C Dijkstra; Jitske Weegenaar; Peter Kenemans; René H M Verheijen
Cultures of ovarian surface epithelium from women with and without a hereditary predisposition to develop female adnexal carcinoma.
Gynecologic oncology 2004;92(3):819-26.
2004: Albertus T Hesselink; Adriaan J C van den Brule; Antoinette A T P Brink; Johannes Berkhof; Folkert J van Kemenade; René H M Verheijen; Peter J F Snijders
Comparison of hybrid capture 2 with in situ hybridization for the detection of high-risk human papillomavirus in liquid-based cervical samples.
Cancer 2004;102(1):11-8.
2004: Renske D M Steenbergen; Debbie Kramer; Boudewijn J M Braakhuis; Peter L Stern; René H M Verheijen; Chris J L M Meijer; Peter J F Snijders
TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia.
Journal of the National Cancer Institute 2004;96(4):294-305.
2003: Saskia Bulk; Otto J Visser; Lawrence Rozendaal; René H M Verheijen; C J L M Meijer
Incidence and survival rate of women with cervical cancer in the Greater Amsterdam area.
British journal of cancer 2003;89(5):834-9.
2003: Auke D Adema; Jacqueline Cloos; René H M Verheijen; Boudewijn J M Braakhuis; P E Bryant
Comparison of bleomycin and radiation in the G2 assay of chromatid breaks.
International journal of radiation biology 2003;79(8):655-61.
2003: Jurgen M J Piek; René H M Verheijen; Peter Kenemans; L F A G Massuger; Hans Bulten; Paulus van Diest
BRCA1/2-related ovarian cancers are of tubal origin: a hypothesis.
Gynecologic oncology 2003;90(2):491.
2003: Marrije R Buist; Rik Pijpers; Arthur van Lingen; Paulus van Diest; Jan Dijkstra; Peter Kenemans; René H M Verheijen
Laparoscopic detection of sentinel lymph nodes followed by lymph node dissection in patients with early stage cervical cancer.
Gynecologic oncology 2003;90(2):290-6.
2003: Mark van Duin; Renske D M Steenbergen; Jillian de Wilde; Theo J M Helmerhorst; René H M Verheijen; Elle K J Risse; Chris J L M Meijer; Peter J F Snijders
Telomerase activity in high-grade cervical lesions is associated with allelic imbalance at 6Q14-22.
International journal of cancer. Journal international du cancer 2003;105(5):577-82.
2003: Antoine M Snijders; Marlies E Nowee; Jane Fridlyand; Jurgen M J Piek; Josephine C Dorsman; Ajay N Jain; Daniel Pinkel; Paulus van Diest; René H M Verheijen; Donna G Albertson
Genome-wide-array-based comparative genomic hybridization reveals genetic homogeneity and frequent copy number increases encompassing CCNE1 in fallopian tube carcinoma.
Oncogene 2003;22(27):4281-6.
2003: Jurgen M J Piek; René H M Verheijen; Fred H Menko; A P M Jongsma; Jitske Weegenaar; Johan J P Gille; Gerard Pals; Peter Kenemans; Paulus van Diest
Expression of differentiation and proliferation related proteins in epithelium of prophylactically removed ovaries from women with a hereditary female adnexal cancer predisposition.
Histopathology 2003;43(1):26-32.
2003: Jurgen M J Piek; Josephine C Dorsman; Ronald P Zweemer; René H M Verheijen; Paulus van Diest; Terence J Colgan
Women harboring BRCA1/2 germline mutations are at risk for breast and female adnexal carcinoma.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2003;22(3):315-6; author reply 315-6.
2003: Frank W Bouwmeester; Andries R Jonkhoff; René H M Verheijen; Herman P van Geijn
Successful treatment of life-threatening postpartum hemorrhage with recombinant activated factor VII.
Obstetrics and gynecology 2003;101(6):1174-6.
2003: Jurgen M J Piek; Bas Torrenga; Brenda B J Hermsen; René H M Verheijen; Ronald P Zweemer; Johan J P Gille; Peter Kenemans; Paulus van Diest; Fred H Menko
Histopathological characteristics of BRCA1- and BRCA2-associated intraperitoneal cancer: a clinic-based study.
Familial cancer 2003;2(2):73-8.
2002: René H M Verheijen; H Boonstra; F H Menko; J de Graaff; H F A Vasen; G G Kenter
[Recommendations for the management of women with an increased genetic risk of gynaecological cancer].
Nederlands tijdschrift voor geneeskunde 2002;146(50):2414-8.
2002: A P M Jongsma; Jurgen M J Piek; Ronald P Zweemer; René H M Verheijen; J W T Klein Gebbinck; G J van Kamp; Ian J Jacobs; P Shaw; Paulus van Diest; Peter Kenemans
Molecular evidence for putative tumour suppressor genes on chromosome 13q specific to BRCA1 related ovarian and fallopian tube cancer.
Molecular pathology : MP 2002;55(5):305-9.
2002: Patricia A Shaw; John R McLaughlin; Ronald P Zweemer; Steven A Narod; Harvey A Risch; René H M Verheijen; A Ryan; Fred H Menko; Peter Kenemans; Ian J Jacobs
Histopathologic features of genetically determined ovarian cancer.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2002;21(4):407-11.
2002: Iwona van Zanten-Przybysz; Carla F M Molthoff; Jacqueline Klein Gebbinck; Silvia von Mensdorff-Pouilly; Rob A Verstraeten; Peter Kenemans; René H M Verheijen
Cellular and humoral responses after multiple injections of unconjugated chimeric monoclonal antibody MOv18 in ovarian cancer patients: a pilot study.
Journal of cancer research and clinical oncology 2002;128(9):484-92.
2002: Eltjo M J Schutter; Elvira M Davelaar; Gerard J van Kamp; Rob A Verstraeten; Peter Kenemans; René H M Verheijen
The differential diagnostic potential of a panel of tumor markers (CA 125, CA 15-3, and CA 72-4 antigens) in patients with a pelvic mass.
American journal of obstetrics and gynecology 2002;187(2):385-92.
2002: Renske D M Steenbergen; Vanessa E OudeEngberink; Debbie Kramer; Henri F J Schrijnemakers; René H M Verheijen; Chris J L M Meijer; Peter J F Snijders
Down-regulation of GATA-3 expression during human papillomavirus-mediated immortalization and cervical carcinogenesis.
The American journal of pathology 2002;160(6):1945-51.
2002: M A E Nobbenhuis; Theo J M Helmerhorst; Adriaan J C van den Brule; Lawrence Rozendaal; Lies H Jaspars; Feja J Voorhorst; René H M Verheijen; C J L M Meijer
Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women.
Journal of clinical pathology 2002;55(6):435-9.
2002: Mark van Duin; Peter J F Snijders; Henri F J Schrijnemakers; Feja J Voorhorst; Lawrence Rozendaal; M A E Nobbenhuis; Adriaan J C van den Brule; René H M Verheijen; Theo J M Helmerhorst; Chris J L M Meijer
Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance.
International journal of cancer. Journal international du cancer 2002;98(4):590-5.
2001: M A E Nobbenhuis; Theo J M Helmerhorst; Adriaan J C van den Brule; Lawrence Rozendaal; Feja J Voorhorst; P Dick Bezemer; René H M Verheijen; Chris J L M Meijer
Cytological regression and clearance of high-risk human papillomavirus in women with an abnormal cervical smear.
Lancet 2001;358(9295):1782-3.
2001: Jurgen M J Piek; Paulus van Diest; Ronald P Zweemer; J W Jansen; RJ Poort-Keesom; Fred H Menko; Johan J P Gille; A P M Jongsma; Gerard Pals; Peter Kenemans; René H M Verheijen
Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer.
The Journal of pathology 2001;195(4):451-6.
2001: Ronald P Zweemer; A Ryan; Antoine M Snijders; M A Hermsen; Gerrit A Meijer; U Beller; Fred H Menko; Ian J Jacobs; Jan P A Baak; René H M Verheijen; Peter Kenemans; Paulus van Diest
Comparative genomic hybridization of microdissected familial ovarian carcinoma: two deleted regions on chromosome 15q not previously identified in sporadic ovarian carcinoma.
Laboratory investigation; a journal of technical methods and pathology 2001;81(10):1363-70.
2001: Ronald P Zweemer; René H M Verheijen; J W Coebergh; Ian J Jacobs; Paulus van Diest; Johan J P Gille; S Skates; Fred H Menko; Leo P ten Kate; Peter Kenemans
Survival analysis in familial ovarian cancer, a case control study.
European journal of obstetrics, gynecology, and reproductive biology 2001;98(2):219-23.
2001: Jurgen M J Piek; Paulus van Diest; Ronald P Zweemer; Peter Kenemans; René H M Verheijen
Tubal ligation and risk of ovarian cancer.
Lancet 2001;358(9284):844.
2001: Jurgen M J Piek; Paulus van Diest; René H M Verheijen; Peter Kenemans
Cell cycle-related proteins p21 and bcl-2: markers of differentiation in the human fallopian tube.
Histopathology 2001;38(5):481-2.
2001: Iwona van Zanten-Przybysz; Carla F M Molthoff; Jan C Roos; René H M Verheijen; AC van Hof; Marrije R Buist; HM Prinssen; W den Hollander; Peter Kenemans
Influence of the route of administration on targeting of ovarian cancer with the chimeric monoclonal antibody MOv18: i.v. vs. i.p.
International journal of cancer. Journal international du cancer 2001;92(1):106-14.
2001: M A E Nobbenhuis; Chris J L M Meijer; Adriaan J C van den Brule; Lawrence Rozendaal; Feja J Voorhorst; Elle K J Risse; René H M Verheijen; Theo J M Helmerhorst
Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia.
British journal of cancer 2001;84(6):796-801.
2000: Silvia von Mensdorff-Pouilly; FG Snijdewint; AA Verstraeten; René H M Verheijen; Peter Kenemans
Human MUC1 mucin: a multifaceted glycoprotein.
The International journal of biological markers 2000;15(4):343-56.
2000: Hetty J Bontkes; Tanja D de Gruijl; AJ van den Muysenberg; René H M Verheijen; MJ Stukart; Chris J L M Meijer; Rik J Scheper; Simon N Stacey; Margaret Duggan-Keen; Peter L Stern; Stephen Man; Leszek K Borysiewicz; Jan M M Walboomers
Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes in women with cervical neoplasia.
International journal of cancer. Journal international du cancer 2000;88(1):92-8.
2000: Marcel V Jacobs; Jan M M Walboomers; Peter J F Snijders; Feja J Voorhorst; René H M Verheijen; Nathalie Fransen-Daalmeijer; Chris J L M Meijer
Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types.
International journal of cancer. Journal international du cancer 2000;87(2):221-7.
2000: René H M Verheijen; Rik Pijpers; Paulus van Diest; C W Burger; Marrije R Buist; Peter Kenemans
Sentinel node detection in cervical cancer.
Obstetrics and gynecology 2000;96(1):135-8.
2000: Iwona van Zanten-Przybysz; Carla F M Molthoff; Jan C Roos; Marian A B D Plaizier; Gerard W M Visser; Rik Pijpers; Peter Kenemans; René H M Verheijen
Radioimmunotherapy with intravenously administered 131I-labeled chimeric monoclonal antibody MOv18 in patients with ovarian cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(7):1168-76.
2000: J Joris Hage; Judith J M L Dekker; Refaat B Karim; René H M Verheijen; Elisabeth Bloemena
Ovarian cancer in female-to-male transsexuals: report of two cases.
Gynecologic oncology 2000;76(3):413-5.
2000: Mark van Duin; Peter J F Snijders; MT Vossen; E Klaassen; Feja J Voorhorst; René H M Verheijen; Theo J M Helmerhorst; Chris J L M Meijer; Jan M M Walboomers
Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis.
The Journal of general virology 2000;81(Pt 2):317-25.
2000: Ronald P Zweemer; Paulus van Diest; René H M Verheijen; A Ryan; Johan J P Gille; Rolf Sijmons; Ian J Jacobs; Fred H Menko; Peter Kenemans
Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations.
Gynecologic oncology 2000;76(1):45-50.
1999: Eltjo M J Schutter; Velja Mijatovic; astrid kok; Gerard J van Kamp; Rob A Verstraeten; René H M Verheijen
Urinary gonadotropin peptide (UGP) and serum CA 125 in gynaecologic practice, a clinical prospective study.
Anticancer research 1999;19(6C):5551-7.
1999: Hetty J Bontkes; Tanja D de Gruijl; A Bijl; René H M Verheijen; Chris J L M Meijer; Rik J Scheper; Peter L Stern; JE Burns; Norman J Maitland; Jan M M Walboomers
Human papillomavirus type 16 E2-specific T-helper lymphocyte responses in patients with cervical intraepithelial neoplasia.
The Journal of general virology 1999;80 ( Pt 9)():2453-9.
1999: Marcel V Jacobs; Jan M M Walboomers; J van Beek; Feja J Voorhorst; René H M Verheijen; Chris J L M Meijer; Adriaan J C van den Brule; Theo J M Helmerhorst; Peter J F Snijders
A quantitative polymerase chain reaction-enzyme immunoassay for accurate measurements of human papillomavirus type 16 DNA levels in cervical scrapings.
British journal of cancer 1999;81(1):114-21.
1999: HW Nijman; Peter Kenemans; RJ Poort-Keesom; Rob A Verstraeten; S Mensdorff-Pouilly; René H M Verheijen; CJ Melief; JH Hilgers; Chris J L M Meijer
Influence of chemotherapy on the expression of p53, HER-2/neu and proliferation markers in ovarian cancer.
European journal of obstetrics, gynecology, and reproductive biology 1999;83(2):201-6.
1999: René H M Verheijen; Silvia von Mensdorff-Pouilly; Gerard J van Kamp; Peter Kenemans
CA 125: fundamental and clinical aspects.
Seminars in cancer biology 1999;9(2):117-24.
1999: Tanja D de Gruijl; Hetty J Bontkes; AJ van den Muysenberg; Johan W van Oostveen; MJ Stukart; René H M Verheijen; N van der Vange; P J Snijders; Chris J L M Meijer; Jan M M Walboomers; Rik J Scheper
Differences in cytokine mRNA profiles between premalignant and malignant lesions of the uterine cervix.
European journal of cancer (Oxford, England : 1990) 1999;35(3):490-7.
1999: Tanja D de Gruijl; Hetty J Bontkes; Fedro Alessandro Peccatori; M P Gallee; Theo J M Helmerhorst; René H M Verheijen; J Aarbiou; WM Mulder; Jan M M Walboomers; Chris J L M Meijer; N van de Vange; Rik J Scheper
Expression of CD3-zeta on T-cells in primary cervical carcinoma and in metastasis-positive and -negative pelvic lymph nodes.
British journal of cancer 1999;79(7-8):1127-32.
1999: Ronald P Zweemer; René H M Verheijen; Fred H Menko; Johan J P Gille; Paulus van Diest; J W Coebergh; Patricia A Shaw; Ian J Jacobs; Peter Kenemans
Differences between hereditary and sporadic ovarian cancer.
European journal of obstetrics, gynecology, and reproductive biology 1999;82(2):151-3.
1999: Hetty J Bontkes; Tanja D de Gruijl; Jan M M Walboomers; J T Schiller; J Dillner; Theo J M Helmerhorst; René H M Verheijen; Rik J Scheper; Chris J L M Meijer
Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16.
The Journal of general virology 1999;80 ( Pt 2)():409-17.
1999: Tanja D de Gruijl; Hetty J Bontkes; Jan M M Walboomers; Pierre Coursaget; MJ Stukart; C Dupuy; Esther W M Kueter; René H M Verheijen; Theo J M Helmerhorst; Margaret Duggan-Keen; Peter L Stern; Chris J L M Meijer; Rik J Scheper
Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome.
The Journal of general virology 1999;80 ( Pt 2)():399-408.
1999: Quentin Davies; Alan C Perkins; Jan C Roos; Carla F M Molthoff; René H M Verheijen; Malcolm Frier; Peter Kenemans; TJ Broadhead; M Sopwith; EM Symonds
An immunoscintigraphic evaluation of the engineered human monoclonal antibody (hCTMO1) for use in the treatment of ovarian carcinoma.
British journal of obstetrics and gynaecology 1999;106(1):31-7.
1998: Hetty J Bontkes; Mark van Duin; Tanja D de Gruijl; Margaret Duggan-Keen; Jan M M Walboomers; MJ Stukart; René H M Verheijen; Theo J M Helmerhorst; Chris J L M Meijer; Rik J Scheper; F R Stevens; P A Dyer; PJ Sinnott; Peter L Stern
HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants.
International journal of cancer. Journal international du cancer 1998;78(2):166-71.
1998: HM Prinssen; Carla F M Molthoff; René H M Verheijen; TJ Broadhead; Peter Kenemans; Jan C Roos; Quentin Davies; AC van Hof; Malcolm Frier; W den Hollander; Abraham Wilhelm; T S Baker; M Sopwith; EM Symonds; Alan C Perkins
Biodistribution of 111In-labelled engineered human antibody CTM01 (hCTM01) in ovarian cancer patients: influence of prior administration of unlabelled hCTM01.
Cancer immunology, immunotherapy : CII 1998;47(1):39-46.
1998: Peter J F Snijders; Mark van Duin; Jan M M Walboomers; Renske D M Steenbergen; Elle K J Risse; Theo J M Helmerhorst; René H M Verheijen; Chris J L M Meijer
Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial neoplasia grade III lesions: strong association with elevated messenger RNA levels of its catalytic subunit and high-risk human papillomavirus DNA.
Cancer research 1998;58(17):3812-8.
1998: Tanja D de Gruijl; Hetty J Bontkes; Jan M M Walboomers; MJ Stukart; F S Doekhie; Adriana J Remmink; Theo J M Helmerhorst; René H M Verheijen; Margaret Duggan-Keen; Peter L Stern; Chris J L M Meijer; Rik J Scheper
Differential T helper cell responses to human papillomavirus type 16 E7 related to viral clearance or persistence in patients with cervical neoplasia: a longitudinal study.
Cancer research 1998;58(8):1700-6.
1998: Ronald P Zweemer; René H M Verheijen; Johan J P Gille; Paulus van Diest; Gerard Pals; Fred H Menko
Clinical and genetic evaluation of thirty ovarian cancer families.
American journal of obstetrics and gynecology 1998;178(1 Pt 1):85-90.
1997: Carla F M Molthoff; HM Prinssen; Peter Kenemans; AC van Hof; W den Hollander; René H M Verheijen
Escalating protein doses of chimeric monoclonal antibody MOv18 immunoglobulin G in ovarian carcinoma patients: a phase I study.
Cancer 1997;80(12 Suppl):2712-20.
1997: R E van Rijswijk; Klaas Hoekman; C W Burger; René H M Verheijen; Jan B Vermorken
Experience with intraperitoneal cisplatin and etoposide and i.v. sodium thiosulphate protection in ovarian cancer patients with either pathologically complete response or minimal residual disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(12):1235-41.
1997: C J Vennegoor; HW Nijman; J W Drijfhout; L Vernie; Rob A Verstraeten; Silvia von Mensdorff-Pouilly; JH Hilgers; René H M Verheijen; W M Kast; CJ Melief; Peter Kenemans
Autoantibodies to p53 in ovarian cancer patients and healthy women: a comparison between whole p53 protein and 18-mer peptides for screening purposes.
Cancer letters 1997;116(1):93-101.
1997: Tanja D de Gruijl; Hetty J Bontkes; Jan M M Walboomers; J T Schiller; MJ Stukart; B S Groot; M M Chabaud; Adriana J Remmink; René H M Verheijen; Theo J M Helmerhorst; Chris J L M Meijer; Rik J Scheper
Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia.
Journal of the National Cancer Institute 1997;89(9):630-8.
1996: Tanja D de Gruijl; Hetty J Bontkes; Jan M M Walboomers; MJ Stukart; A A Robbesom; B M von Blomberg-van der Flier; P Herbrink; Adriana J Remmink; René H M Verheijen; Theo J M Helmerhorst; Chris J L M Meijer; Rik J Scheper
Analysis of IgG reactivity against Human Papillomavirus type-16 E7 in patients with cervical intraepithelial neoplasia indicates an association with clearance of viral infection: results of a prospective study.
International journal of cancer. Journal international du cancer 1996;68(6):731-8.
1996: A C van Hof; Carla F M Molthoff; Quentin Davies; Alan C Perkins; René H M Verheijen; Peter Kenemans; W den Hollander; Abraham Wilhelm; T S Baker; M Sopwith; Malcolm Frier; EM Symonds; Jan C Roos
Biodistribution of (111)indium-labeled engineered human antibody CTMO1 in ovarian cancer patients: influence of protein dose.
Cancer research 1996;56(22):5179-85.
1996: Tanja D de Gruijl; Hetty J Bontkes; MJ Stukart; Jan M M Walboomers; Adriana J Remmink; René H M Verheijen; Theo J M Helmerhorst; Chris J L M Meijer; Rik J Scheper
T cell proliferative responses against human papillomavirus type 16 E7 oncoprotein are most prominent in cervical intraepithelial neoplasia patients with a persistent viral infection.
The Journal of general virology 1996;77 ( Pt 9)():2183-91.
1993: K A Yedema; René H M Verheijen; Peter Kenemans; C P T Schijf; G F Borm; M F Segers; Chris M G Thomas
Identification of patients with persistent trophoblastic disease by means of a normal human chorionic gonadotropin regression curve.
American journal of obstetrics and gynecology 1993;168(3 Pt 1):787-92.
1992: L F A G Massuger; Chris M G Thomas; M F Segers; Frans H M Corstens; René H M Verheijen; Peter Kenemans; Lambert G Poels
Specific and nonspecific immunoassays to detect HAMA after administration of indium-111-labeled OV-TL 3 F(ab')2 monoclonal antibody to patients with ovarian cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1992;33(11):1958-63.
1991: L F A G Massuger; Otto Boerman; Frans H M Corstens; René H M Verheijen; RA Claessens; Lambert G Poels; W J van den Broek; Peter Kenemans
Biodistribution of iodine-125 and indium-111 labeled OV-TL 3 intact antibodies and F(ab')2 fragments in tumor-bearing athymic mice.
Anticancer research 1991;11(6):2051-7.
1991: L F A G Massuger; Peter Kenemans; RA Claessens; René H M Verheijen; Frans H M Corstens
Detection and localization of ovarian cancer with radiolabeled monoclonal antibodies.
European journal of obstetrics, gynecology, and reproductive biology 1991;41(1):47-63.
1991: L F A G Massuger; RA Claessens; Peter Kenemans; René H M Verheijen; Otto Boerman; A P Meeuwis; C P T Schijf; Wilhelmina C A M Buijs; T G Hanselaar; Frans H M Corstens
Kinetics and biodistribution in relation to tumour detection with 111In-labelled OV-TL 3 F(ab')2 in patients with ovarian cancer.
Nuclear medicine communications 1991;12(7):593-609.
1990: L F A G Massuger; Peter Kenemans; RA Claessens; René H M Verheijen; C P T Schijf; S P Strijk; Lambert G Poels; R G van Hoesel; Frans H M Corstens
Immunoscintigraphy of ovarian cancer with indium-111-labeled OV-TL 3 F(ab')2 monoclonal antibody.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1990;31(11):1802-10.
1988: Peter Kenemans; C A Yedema; JH Hilgers; L F A G Massuger; René H M Verheijen; Chris M G Thomas; Lambert G Poels
Clinical applications of monoclonal antibodies against ovarian cancer-associated antigens.
European journal of obstetrics, gynecology, and reproductive biology 1988;29(3):207-18.
1985: P Kenemans; René H M Verheijen; A M Leloux; Lambert G Poels
Prospects and applications of monoclonal antibodies in gynecological oncology.
European journal of obstetrics, gynecology, and reproductive biology 1985;19(6):340-6.